Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

• Tomokazu Ohishi ,

  Roles Conceptualization, Investigation, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: ohishit@bikaken.or.jp

  Affiliation Institute of Microbial Chemistry (BIKAKEN), Numazu, Microbial Chemistry Research Foundation, Numazu-shi, Shizuoka, Japan

  https://orcid.org/0000-0002-9039-4474

  ⨯
• Takayuki Hishiki,

  Roles Data curation, Investigation, Writing – review & editing

  Current address: Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan

  Affiliation Kanagawa Prefectural Institute of Public Health, Chigasaki, Kanagawa, Japan

  ⨯
• Mirza S. Baig,

  Roles Data curation, Investigation, Software, Writing – review & editing

  Affiliation Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology (IIT), Simrol, Indore, India

  ⨯
• Sajjan Rajpoot,

  Roles Investigation, Software, Writing – review & editing

  Affiliation Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology (IIT), Simrol, Indore, India

  https://orcid.org/0000-0003-4126-7011

  ⨯
• Uzma Saqib,

  Roles Investigation, Software, Writing – review & editing

  Affiliation Department of Chemistry, Indian Institute of Technology (IIT), Simrol, Indore, India

  ⨯
• Tomohiko Takasaki,

  Roles Project administration, Writing – review & editing

  Affiliation Kanagawa Prefectural Institute of Public Health, Chigasaki, Kanagawa, Japan

  ⨯
• Yukihiko Hara

  Roles Project administration, Resources, Writing – review & editing

  Affiliation Tea Solutions, Hara Office Inc., Sumida-ku, Tokyo, Japan

  ⨯